Clinical TrialsSearch results
Number of results: 854
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype
- asthma
- Hirashima Aki
- 2021-03-11
Recruiting
- Testing Safe Extension of Benralizumab Dosing Intervals
- asthma
- Kaneko Takeshi
- 2024-08-06
Other
- Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)
- Asthma
- Asthma QOL Research Study Group
- 2007-06-01
Other
- A randomized phase II/III study of ACNU versus Procarbazine plus ACNU as a postoperative chemoradiotherapy for strocytoma grade 3 and 4(JCOG0305, ACNU+PCZ PhaseII/III)
- astrocytoma grade 3/4
- Japan Clinical Oncology Group(JCOG)
- 2005-09-02
Other
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
- Atherosclerotic Cardiovascular Disease
- Matsumoto Hiroki
- 2023-01-31
Recruiting
- A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD
- Atopic Dermatitis
- Jain Neal
- 2023-07-01
Recruiting
- A Phase 3, Open-label Study Assessing Self-administered Rocatinlimab (AMG 451) in Subjects With Moderate-to-severe AD
- Atopic Dermatitis
- Chen Sarah
- 2024-04-23
Recruiting
- Bioequivalence study of JTE-052
- atopic dermatitis
- Mitsui Hironori
- 2024-03-15
Recruiting
- Phase 3, 52-week Study Evaluating Rocatinlimab (AMG 451) in Adolescent Subjects With Moderate-to-severe AD
- Atopic Dermatitis
- Bouloc Anne
- 2023-04-16
Other
- A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD
- Atopic Dermatitis
- Schwartz-Sagi Liat
- 2023-04-03